ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Capital expenditures 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3.0MFY2025 · since FY2017: $2.4M → $3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.0M | -19.2% |
| FY2024 | $3.7M | -65.7% |
| FY2023 | $10.7M | -34.6% |
| FY2022 | $16.3M | -73.5% |
| FY2021 | $61.7M | +228.4% |
| FY2020 | $18.8M | +67.9% |
| FY2019 | $11.2M | +77.8% |
| FY2018 | $6.3M | +160.2% |
| FY2017 | $2.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice